Vorapaxar

From WikiMD's Wellnesspedia

What is Vorapaxar?[edit | edit source]


Vorapaxar structure.svg
Vorapaxar ball-and-stick model.png
PAR1 Vorapaxar 3.jpg


What are the uses of this medicine?[edit | edit source]

Zontivity is a prescription medicine used to treat people who have

  • had a heart attack or
  • reduced blood flow in their legs (peripheral arterial disease).
  • Zontivity is used with aspirin and/or clopidogrel to lower your chance of having another serious problem with your heart or blood vessels, such as heart attack, stroke, or death.


How does this medicine work?[edit | edit source]

  • Vorapaxar (vor" a pax' ar) is an inhibitor of the protease-activated receptor 1 (PAR-1) that is found on platelets and is activated by thrombin resulting in platelet aggregation and formation of a vascular clot.
  • The aggregation of platelets also plays an important role in the growth of atheromatous plaques, which can lead to coronary, cerebral and peripheral arterial occlusions.
  • In large clinical trials, vorapaxar therapy has been shown to decrease the frequency of recurrence of myocardial infarction and cardiovascular events in patients at high risk of complications of atherosclerosis.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients with:

  • have had a stroke or "mini stroke" (also known as transient ischemic attack or TIA)
  • have had bleeding in your brain
  • currently have unusual bleeding, such as bleeding in your head, stomach or intestines (an ulcer).

If you have a stroke, TIA, or bleeding in your brain while taking Zontivity your doctor should stop your treatment with Zontivity. Follow your doctor's instructions about stopping Zontivity.


What drug interactions can this medicine cause?[edit | edit source]

  • Avoid concomitant use of Zontivity with strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, posaconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, boceprevir, telaprevir, telithromycin and conivaptan).
  • Avoid concomitant use of Zontivity with strong inducers of CYP3A (e.g., rifampin, carbamazepine, St. John's Wort and phenytoin).


Is this medicine FDA approved?[edit | edit source]

  • This medicine is approved in the year 2014.


How should this medicine be used?[edit | edit source]

Recommended Dosage:

  • Take one tablet of Zontivity 2.08 mg orally once daily, with or without food.

Administration

  • Take Zontivity exactly as prescribed by your doctor.
  • Take Zontivity 1 time each day.
  • Take Zontivity with or without food.
  • Take Zontivity with aspirin and/or clopidogrel as prescribed by your doctor.
  • Do not stop taking Zontivity without first talking to the doctor who prescribed it for you.
  • If you take too much Zontivity, call your doctor, or go to the nearest emergency room right away.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Tablets: 2.08 mg vorapaxar.

This medicine is available in fallowing brand namesː

  • Zontivity '


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

  • Bleeding including life-threatening and fatal bleeding, is the most commonly reported adverse reaction.
  • Anemia (low level of red blood cells)
  • Depression
  • Rash


What special precautions should I follow?[edit | edit source]

  • Like other antiplatelet agents, Zontivity increases the risk of bleeding. Avoid concomitant use of warfarin or other anticoagulants.
  • Avoid concomitant use of Zontivity with strong CYP3A inhibitors or inducers.


What to do in case of emergency/overdose?[edit | edit source]

Management of overdosage:

  • There is no known treatment to reverse the antiplatelet effect of Zontivity, and neither dialysis nor platelet transfusion can be expected to be beneficial if bleeding occurs after overdose.
  • Inhibition of platelet aggregation can be expected for weeks after discontinuation of normal dosing .
  • There is no standard test available to assess the risk of bleeding in an overdose situation.


Can this medicine be used in pregnancy?[edit | edit source]

  • Available data from postmarketing experience with Zontivity use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.


Can this medicine be used in children?[edit | edit source]

  • The safety and effectiveness of Zontivity in pediatric patients have not been established.


What are the active and inactive ingredients in this medicine?[edit | edit source]

  • Active ingredient: vorapaxar sulfate
  • Inactive ingredients:
  • Tablet: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, and magnesium stearate
  • Film coating: lactose monohydrate, hypromellose, titanium dioxide, triacetin (glycerol triacetate), and iron oxide yellow


Who manufactures and distributes this medicine?[edit | edit source]

  • Manufactured for:

Aralez Pharmaceuticals US Inc. 300 Interpace Parkway Morris Corporate Center 1, Building C3 Parsippany NJ 07054 United States


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store Zontivity at room temperature between 68°F to 77°F (20°C to 25°C).
  • Keep Zontivity in the bottle it comes in.
  • Keep the bottle tightly closed.
  • The Zontivity bottle contains a desiccant packet to help keep your medicine dry (protect it from moisture). Keep the desiccant packet in the bottle. Do not throw away the desiccant packet.
  • Store blister packs of Zontivity in the original package it comes in.


Vorapaxar Resources

Find a healthcare provider anywhere in the world quickly and easily!

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

WikiMD.png


WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.